Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, ...

Cipla Ltd is one of the leading pharmaceutical companies in India ... Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1500 products across wide range of th... We ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...

the consumer healthcare subsidiary of Cipla Ltd purchased the nutritional supplement brand Endura Mass from Medinnbelle Herbalcare. Products and services Cipla is among India’s biggest ...

Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the ...

Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...